Mirati Therapeutics | Ativo Circulante



Current Assets Alterar Data
Agios Pharmaceuticals USD 968.62M 3.02M 2025-03
Alnylam Pharmaceuticals USD 3.27B 27.03M 2025-03
Amgen USD 26.93B 2.1B 2025-03
Astellas Pharma JPY 1.2T 2.56B 2025-03
AstraZeneca USD 26.14B 312M 2025-03
Bayer EUR 34.83B 388M 2025-03
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Eisai JPY 727.66B 33.44B 2025-03
Eli Lilly USD 41.26B 8.52B 2025-03
Exelixis USD 1.4B 71.08M 2025-04
Gilead Sciences USD 19.17B 4.39B 2024-12
GlaxoSmithKline GBP 18.08B 1.09B 2025-03
Incyte USD 3.23B 7.24M 2025-03
Ionis Pharmaceuticals USD 2.42B 201.36M 2025-03
J&J USD 71.55B 15.66B 2025-03
Merck USD 35.5B 3.28B 2025-03
Moderna USD 6.77B 1.33B 2025-03
Novartis USD 29.7B 1.56B 2024-12
Pfizer USD 45.86B 4.5B 2025-03
Roche Holding CHF 40.04B 6.41B 2024-12
Sarepta Therapeutics USD 2.43B 640.93M 2025-03
Takeda JPY 2.52T 233.1B 2025-03
Ultragenyx Pharmaceutical USD 817.12M 17.52M 2024-12



Mirati Therapeutics Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.